Dubai Telegraph - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.216125
AFN 74.621719
ALL 91.702089
AMD 416.711307
ANG 2.055386
AOA 1052.739855
ARS 1733.529937
AUD 1.611486
AWG 2.069317
AZN 1.94802
BAM 1.955853
BBD 2.311953
BDT 140.963825
BGN 1.932634
BHD 0.43271
BIF 3453.378665
BMD 1.148026
BND 1.464633
BOB 11.679317
BRL 5.885123
BSD 1.147826
BTN 110.061986
BWP 15.566355
BYN 3.489479
BYR 22501.312563
BZD 2.308653
CAD 1.605302
CDF 2653.089103
CHF 0.946961
CLF 0.027903
CLP 1101.772158
CNY 7.700443
CNH 7.687671
COP 3638.014511
CRC 513.511697
CUC 1.148026
CUP 30.422693
CVE 110.267992
CZK 24.315711
DJF 204.404656
DKK 7.475481
DOP 67.991549
DZD 153.69284
EGP 59.843733
ERN 17.220392
ETB 187.497071
FJD 2.544489
FKP 0.853761
GBP 0.859166
GEL 2.990619
GGP 0.853761
GHS 13.212359
GIP 0.853761
GMD 84.368659
GNF 10073.9293
GTQ 8.758238
GYD 240.116515
HKD 9.006093
HNL 30.808702
HRK 7.535187
HTG 150.023417
HUF 362.498439
IDR 20371.724053
ILS 3.482979
IMP 0.853761
INR 109.926431
IQD 1503.734254
IRR 1578076.747429
ISK 139.405036
JEP 0.853761
JMD 181.144126
JOD 0.813942
JPY 180.034032
KES 148.841865
KGS 100.395388
KHR 4675.106495
KMF 491.355358
KPW 1033.223901
KRW 1589.413473
KWD 0.354165
KYD 0.956622
KZT 511.321648
LAK 25709.585645
LBP 102792.341533
LKR 380.718672
LRD 199.155404
LSL 18.699326
LTL 3.389823
LVL 0.694429
LYD 7.291166
MAD 10.933797
MDL 20.151459
MGA 4985.113557
MKD 61.526669
MMK 2410.470116
MNT 4129.27924
MOP 9.275911
MRU 45.984047
MUR 54.714996
MVR 17.737289
MWK 1990.445341
MXN 19.690933
MYR 4.683681
MZN 73.35324
NAD 18.699326
NGN 1528.126437
NIO 42.240962
NOK 10.811898
NPR 176.098011
NZD 2.00755
OMR 0.441414
PAB 1.147831
PEN 3.875205
PGK 5.107116
PHP 71.941631
PKR 318.162548
PLN 4.356506
PYG 6790.154675
QAR 4.184214
RON 5.261981
RSD 117.387978
RUB 97.016735
RWF 1693.738582
SAR 4.263076
SBD 9.184797
SCR 15.789434
SDG 690.527373
SEK 11.269088
SGD 1.464755
SHP 0.857536
SLE 28.287533
SLL 24073.525056
SOS 656.014944
SRD 43.333965
STD 23761.823474
STN 24.500558
SVC 10.044229
SYP 14926.63631
SZL 18.692426
THB 38.194523
TJS 10.589187
TMT 4.018092
TND 3.343624
TOP 2.764171
TRY 56.004889
TTD 7.793178
TWD 36.501605
TZS 3041.245294
UAH 51.294568
UGX 4511.122407
USD 1.148026
UYU 46.151252
UZS 13516.307891
VES 970.604392
VND 29853.272035
VUV 135.819625
WST 3.148936
XAF 655.957
XAG 0.017427
XAU 0.000264
XCD 3.102598
XCG 2.068747
XDR 0.811714
XOF 655.957
XPF 119.331742
YER 271.680336
ZAR 18.658806
ZMK 10333.615177
ZMW 22.527513
ZWL 369.663952
SSP 6495.73372
MXV 2.232544
  • RBGPF

    0.0000

    69.99

    0%

  • CMSC

    0.1900

    20.67

    +0.92%

  • RYCEF

    0.5200

    19.81

    +2.62%

  • NGG

    1.5700

    77.6

    +2.02%

  • VOD

    0.0600

    17.52

    +0.34%

  • RIO

    2.2500

    98.04

    +2.29%

  • BCC

    0.2200

    75.53

    +0.29%

  • RELX

    0.1100

    34.38

    +0.32%

  • BCE

    -0.2200

    22.28

    -0.99%

  • JRI

    0.1100

    11.61

    +0.95%

  • CMSD

    0.1600

    20.45

    +0.78%

  • GSK

    0.7700

    51.06

    +1.51%

  • AZN

    3.2500

    166.14

    +1.96%

  • BTI

    -0.0700

    56.02

    -0.12%

  • BP

    0.0400

    45.42

    +0.09%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

K.Javed--DT